Published in Medicine and Law Weekly, December 9th, 2005
Under the terms of the settlement agreement, no financial payment will be made by either company, and both companies will dismiss all outstanding claims. No additional terms of the settlement were disclosed.
"We are pleased with the outcome of this settlement," said Tom Moore, CEO of Cord Blood Registry.
Cord Blood Registry has been collecting and processing newborn stem cells for family banking since 1992.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.